Overview

Donepezil Prevents Urinary Retention After Extensive Total Hysterectomy

Status:
Recruiting
Trial end date:
2023-07-15
Target enrollment:
0
Participant gender:
Female
Summary
Patients were randomly divided into experimental group and control group. The control group received routine postoperative treatment, while the experimental group took donepezil 5mg orally before going to bed every night from the first day after surgery. The catheter was removed and residual urine was measured in both groups 14 days after surgery, the catheter was successfully removed when the residual urine was less than 100ml. After 14 days, the patient was returned to the hospital for residual urine test, and the residual urine was repeated until the residual urine volume was less than or equal to 100ml. The incidence of postoperative urinary retention and adverse drug reactions were compared between the two groups.
Phase:
Early Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Treatments:
Donepezil
Criteria
Inclusion Criteria:

1. Age 18-80 years

2. Patients who meet the diagnostic criteria of cervical cancer in the Guidelines for the
Diagnosis and Treatment of Cervical Cancer (the Fourth Edition) and have been
diagnosed by cervical biopsy or colposcopy

3. Patients with surgical indications undergoing extensive abdominal total hysterectomy

4. The person who signed the informed consent.

Exclusion Criteria:

1. Allergic reaction to donepezil hydrochloride, piperidine derivatives or excipients in
preparations

2. Patients with "sick sinus syndrome" or other supraventricular heart conduction
diseases

3. Accompanied by serious liver, kidney and other organ dysfunction, serious infectious
diseases

4. Patients with a history of mental illness and communication disorders

5. At the time of inclusion, patients with urinary tract infection had a history of
urinary tract diseases (stones, congenital malformations, etc.)

6. Patients with intraoperative injury of urinary system, or postoperative ureteral
fistula and vesicovaginal fistula.